Legal Representation
Attorney
Stewart J. Bellus
USPTO Deadlines
Next Deadline
359 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-07-28)
Due Date
July 28, 2026
Grace Period Ends
January 28, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
35 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 28, 2025 | REM3 | E | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | Loading... |
| May 27, 2023 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| May 14, 2023 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Apr 1, 2022 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Oct 27, 2021 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Jul 17, 2021 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Dec 6, 2020 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Nov 17, 2020 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Nov 17, 2020 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Oct 28, 2020 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Jul 28, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| May 12, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 12, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 22, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 7, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 7, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 7, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 6, 2020 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Feb 18, 2020 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Feb 18, 2020 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Feb 18, 2020 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Feb 3, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 3, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 29, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 23, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 6, 2019 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Nov 19, 2019 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Nov 19, 2019 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Oct 29, 2019 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Oct 28, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 22, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 8, 2019 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Oct 3, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 27, 2019 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED | Loading... |
| Sep 26, 2019 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 001
Sodium hyaluronate for use in the manufacture of pharmaceuticals, cosmetics and nutritional supplements
Class 003
Cosmetics
Class 005
Sodium hyaluronate for medical purposes for wrinkle minimizing, reducing and removing sold in pre-filled disposable sterile syringes; sodium hyaluronate for medical purposes for tissue regeneration and for the treatment of abrasion and wound sold in pre-filled disposable sterile syringes; Sodium hyaluronate for medical purposes for the treatment of dry eyes in the form of eye drops; Sodium hyaluronate for medical purposes for the treatment of arthritis sold in pre-filled disposable sterile syringes
Additional Information
Pseudo Mark
PRINCIP HYAL
Classification
International Classes
001
003
005